|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1113-1118
© 2004 The American Association for Thoracic Surgery
General thoracic surgery |
a Department of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom
b Department of Histopathology, Royal Brompton Hospital, London, United Kingdom
Received for publication May 26, 2003; revisions received September 8, 2003; accepted for publication October 2, 2003.
* Address for reprints: Peter Goldstraw, Department of Thoracic Surgery, Royal Brompton Hospital, Sydney St, London SW3 6NP, United Kingdom
p.goldstraw{at}rbh.nthames.nhs.uk
OBJECTIVES: For patients undergoing lung resection for cancer, macroscopic evidence of metastasis is clearly associated with adverse prognosis. However, less is known about the significance of tumor cells detected by using tests such as pleural lavage cytology. To ascertain the frequency and quantify the effect of this finding on survival, we performed a prospective study of intraoperative pleural lavage cytology.
METHODS: Pleural lavage cytology consisted of cytologic analysis of 100 mL of saline irrigated over the lung surface immediately after thoracotomy. Patients were excluded if they had an existing effusion, extreme adhesions, or lateral chest wall invasion or if resection was not performed. Survival was calculated by means of Kaplan-Meier analysis and compared by using log-rank tests. Cox regression was used to ascertain independent predictors of prognosis.
RESULTS: From 1995 through 2003, we performed pleural lavage cytology on 292 patients undergoing thoracotomy for lung cancer. The mean age was 64 (SD, 10) years, and 196 (67%) patients were men. Of 292 samples, 13 (4.5%) showed evidence of malignant cells. The median time to follow-up was 15 months (interquartile range, 1-40 months), with a median survival of 49 months for patients with negative pleural lavage cytology results and 13 months for patients with positive pleural lavage cytology results (P = .002). Univariate prognostic predictors were positive pleural lavage cytology status (P = .03), stage (P = .03), adenocarcinoma (P = .06), and parietal pleural involvement (P = .01). In the final multivariate model only positive pleural lavage cytology status (P = .006) and stage (P = .03) remained significant.
CONCLUSIONS: Intraoperative pleural lavage cytology is a simple addition to intrathoracic staging and an independent predictor of prognosis. Positive results potentially affect survival by upstaging patients to stage IIIB or greater.
Related Article
This article has been cited by other articles:
![]() |
W. Li, Y. Ni, Z. Tu, S. Wu, Z. Wu, and S. Zheng Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 460 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kawachi, Y. Nakazato, K. Masui, H. Takei, Y. Koshi-ishi, and T. Goya Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology? Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 265 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shintani, M. Ohta, T. Iwasaki, N. Ikeda, T. Kanou, E. Tomita, K. Nakagawa, T. Yasumitsu, and Y. Ohno Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 835 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, K. Suzuki, T. Mochizuki, Y. Ohde, H. Kobayashi, H. Nakamura, and F. Toyoda Prognostic significance and possibility in guiding adjuvant therapy of the pleural lavage cytology in patients with non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, March 1, 2009; 8(3): 321 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Higashiyama, K. Oda, J. Okami, J. Maeda, K. Kodama, A. Takenaka, T. Nakayama, and G.-i. Yoneda Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Satoh, R. Hoshi, Y. Ishikawa, T. Horai, S. Okumura, and K. Nakagawa Recurrence Patterns in Patients With Early Stage Non-Small Cell Lung Cancers Undergoing Positive Pleural Lavage Cytology Ann. Thorac. Surg., January 1, 2007; 83(1): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lim Invited commentary Ann. Thorac. Surg., January 1, 2007; 83(1): 202 - 203. [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, N. Okumura, Y. Kokado, K. Miyoshi, T. Matsuoka, and K. Kameyama Clinical Relevance of Intraoperative Pleural Lavage Cytology in Non-Small Cell Lung Cancer Ann. Thorac. Surg., January 1, 2007; 83(1): 204 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomita, T. Shimizu, Y. Matsuzaki, M. Hara, T. Ayabe, and T. Onitsuka Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma Ann. Thorac. Surg., July 1, 2005; 80(1): 276 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Goldstraw and E. Lim Value of intraoperative pleural lavage in staging non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 331 - 331. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |